Literature DB >> 33800464

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming.

Giorgia Di Benedetto1, Silvia Parisi1, Tommaso Russo1, Fabiana Passaro1.   

Abstract

Cell reprogramming can either refer to a direct conversion of a specialized cell into another or to a reversal of a somatic cell into an induced pluripotent stem cell (iPSC). It implies a peculiar modification of the epigenetic asset and gene regulatory networks needed for a new cell, to better fit the new phenotype of the incoming cell type. Cellular reprogramming also implies a metabolic rearrangement, similar to that observed upon tumorigenesis, with a transition from oxidative phosphorylation to aerobic glycolysis. The induction of a reprogramming process requires a nexus of signaling pathways, mixing a range of local and systemic information, and accumulating evidence points to the crucial role exerted by the Hippo pathway components Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ). In this review, we will first provide a synopsis of the Hippo pathway and its function during reprogramming and tissue regeneration, then we introduce the latest knowledge on the interplay between YAP/TAZ and metabolism and, finally, we discuss the possible role of YAP/TAZ in the orchestration of the metabolic switch upon cellular reprogramming.

Entities:  

Keywords:  TAZ; YAP; cell reprogramming; iPSC; metabolic reprogramming

Year:  2021        PMID: 33800464      PMCID: PMC7999074          DOI: 10.3390/metabo11030154

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  176 in total

1.  VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.

Authors:  Wenjing Zhang; Yijun Gao; Peixue Li; Zhubing Shi; Tong Guo; Fei Li; Xiangkun Han; Yan Feng; Chao Zheng; Zuoyun Wang; Fuming Li; Haiquan Chen; Zhaocai Zhou; Lei Zhang; Hongbin Ji
Journal:  Cell Res       Date:  2014-01-24       Impact factor: 25.617

2.  mTORC2 regulates cardiac response to stress by inhibiting MST1.

Authors:  Sebastiano Sciarretta; Peiyong Zhai; Yasuhiro Maejima; Dominic P Del Re; Narayani Nagarajan; Derek Yee; Tong Liu; Mark A Magnuson; Massimo Volpe; Giacomo Frati; Hong Li; Junichi Sadoshima
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

3.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.

Authors:  Luca Azzolin; Tito Panciera; Sandra Soligo; Elena Enzo; Silvio Bicciato; Sirio Dupont; Silvia Bresolin; Chiara Frasson; Giuseppe Basso; Vincenza Guzzardo; Ambrogio Fassina; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2014-06-26       Impact factor: 41.582

Review 4.  The roles and mechanisms of the Hippo/YAP signaling pathway in the nervous system.

Authors:  Xiao-mei Bao; Qing He; Ying Wang; Zhi-hui Huang; Zeng-qiang Yuan
Journal:  Yi Chuan       Date:  2017-07-20

5.  Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.

Authors:  M Sudol
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

6.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.

Authors:  Eunice H Y Chan; Marjaana Nousiainen; Ravindra B Chalamalasetty; Anja Schäfer; Erich A Nigg; Herman H W Silljé
Journal:  Oncogene       Date:  2005-03-17       Impact factor: 9.867

7.  Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis.

Authors:  Yu Jia; Hui-Yan Li; Jue Wang; Ying Wang; Peng Zhang; Ning Ma; Shi-Jing Mo
Journal:  Oncogenesis       Date:  2019-05-10       Impact factor: 7.485

Review 8.  Interplay between Metabolites and the Epigenome in Regulating Embryonic and Adult Stem Cell Potency and Maintenance.

Authors:  Alexandra Harvey; Giuseppina Caretti; Viviana Moresi; Alessandra Renzini; Sergio Adamo
Journal:  Stem Cell Reports       Date:  2019-10-08       Impact factor: 7.765

9.  Identification of RNA-binding proteins that partner with Lin28a to regulate Dnmt3a expression.

Authors:  Silvia Parisi; Daniela Castaldo; Silvia Piscitelli; Chiara D'Ambrosio; Giuseppina Divisato; Fabiana Passaro; Rosario Avolio; Alessia Castellucci; Paolo Gianfico; Mariorosario Masullo; Andrea Scaloni; Tommaso Russo
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

10.  NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.

Authors:  Kate E Hawkins; Shona Joy; Juliette M K M Delhove; Vassilios N Kotiadis; Emilio Fernandez; Lorna M Fitzpatrick; James R Whiteford; Peter J King; Juan P Bolanos; Michael R Duchen; Simon N Waddington; Tristan R McKay
Journal:  Cell Rep       Date:  2016-02-18       Impact factor: 9.423

View more
  4 in total

1.  Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes.

Authors:  Haofei Wang; Benjamin Keepers; Yunzhe Qian; Yifang Xie; Marazzano Colon; Jiandong Liu; Li Qian
Journal:  Cell Stem Cell       Date:  2022-10-06       Impact factor: 25.269

2.  YAP: The nexus between metabolism and cardiac remodeling.

Authors:  Chen Gao; Yibin Wang
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

3.  Lack of WWC2 Protein Leads to Aberrant Angiogenesis in Postnatal Mice.

Authors:  Viktoria Constanze Brücher; Charlotte Egbring; Tanja Plagemann; Pavel I Nedvetsky; Verena Höffken; Hermann Pavenstädt; Nicole Eter; Joachim Kremerskothen; Peter Heiduschka
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 4.  Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers.

Authors:  Guillaume Anthony Odri; Joëlle Tchicaya-Bouanga; Diane Ji Yun Yoon; Dominique Modrowski
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.